The largest database of trusted experimental protocols

5 protocols using dulbecco modified eagle medium (dmem)

1

Quantifying A. fumigatus Infection of A549 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 and CTH−/− cells were maintained at 37°C 5% CO2 in DMEM (Sigma-Aldrich) supplemented with 10% FBS (Sigma-Aldrich) and 1% Penicillin/Streptomycin (Sigma-Aldrich). For all experiments, 105 cells were seeded in 24-well glass bottom plates (Cell Star, Greiner Bio-One) with supplemented DMEM and incubated at 37°C 5% CO2 until confluency. Monolayers were challenged with 105 spores/ml of A. fumigatus wild type and ΔmecB. Following co-incubation, monolayers were washed 3 times with PBS, and cells were fixed with 4% formaldehyde for 10 minutes and permeabilized with 0.2% Triton X-100 (Sigma-Aldrich) for 2 minutes. Finally, cells were stained with 300 nM DAPI for 5 minutes. Stained epithelial cells were imaged on the Nikon Te-2000 widefield microscope described above, using a 20× (0.75 NA) Nikon CFI Plan Apo Lambda objective lens and a 380-nm LED array module with a Nikon UV-2A for DAPI imaging. The number of epithelial cells remaining after infection was calculated with an in-house batch image processing and counting algorithm in Fiji [71 (link)]. The level of epithelial cell detachment for each condition was calculated relative to the number of cells attached in the negative controls with no fungi. All assays were carried out in biological triplicates.
+ Open protocol
+ Expand
2

Erythrocyte Antibody Interaction Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The EAI assay was performed as described in detail elsewhere [9 (link)]. In brief, erythrocytes obtained from Balb/cJRj mice were purified using a Ficoll gradient (Ficoll-Paque, VWR, Cat#17-1440-02) and were stored for up to 2 weeks in DMEM (Gibco, Cat#61965) containing 10% FCS FCS (Amimed, Cat#2-01F30I) at 4°C prior to use.
Serial dilutions of sera were performed in 96-well U-bottom plates (Greiner, Cat#650161) in DMEM containing 10% FCS. 5x105 cfu B. taylorii expressing GFP were added per well and the plates were incubated at 35°C, 5% CO2 for 1h prior to the addition of 106 red blood cells (multiplicity of infection, MOI = 0.5) in 100 μl DMEM containing 10% FCS. The next day, the supernatant was removed, the red blood cells were fixed using 1% PFA (EMS, Cat#EMS-15710) and 0.2% gluturaldehyde (EMS, Cat#16020) in PBS (BioConcept, Cat#3-05F29-I) for 10 min at 4°C in the dark. After quenching with 2% FCS in PBS, the cells were analysed for GFP signal by Flow Cytometry (BD Canto II using HTS autosampler).
+ Open protocol
+ Expand
3

Bioactivity Assay for IL-33 and IL-1β

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK-Blue IL-33/IL-1β (HEK293-ST2L) cells were purchased from Invivogen (Toulouse, France) and cultivated according to the manufacturer's protocol in DMEM (Greiner bio-one, Frickenhausen, Germany) with 5% FCS (GE Healthcare, IL, USA), 2 mM l-glutamine, 100 IU/ml penicillin and 100 IU/ml streptomycin at 5% CO2, 37°C. 30 μg/ml blasticidin, 200 μg/ml hygromycin B Gold and 100 μg/ml zeocin were added after the second passage to maintain the plasmids encoding IL1R1, co-receptor IL-1RAcP, ST2L, and the gene for SEAP. To analyze IL-33 or IL-1β bioactivity, 5 × 104 HEK293-ST2L cells were resuspended in 180 μl medium and were co-incubated with 20 μl of sample. In some experiments, 5 × 104 HEK293-ST2L cells were resuspended in 160 μl and co-incubated with 20 μl sample and 20 μl serum or plasma for a total final volume of 200 μl. For inhibition of proteases, protease inhibitor cocktail (Sigma-Aldrich, Steinhein, Germany) was added in a dilution of 1:160 directly to the cell suspension. After a 22 h incubation period, 40 μl of medium supernatant were co-incubated with 160 μl QUANTI-blue substrate (Invivogen, Toulouse, France) and SEAP activity was measured photometrically at 635 nm for 2 h every minute. Cell viability of HEK293-ST2L cells was assessed by MTT assay to exclude cytotoxic effects mediated by the samples (Roche Life Sciences, Basel, Switzerland).
+ Open protocol
+ Expand
4

Evaluating Hemolytic Activity of RumC1-5

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hemolytic activity of RumC1-5 was evaluated as previously described.30 (link),31 (link),32 (link) Briefly, human erythrocytes (obtained from Divbioscience, NL) were pelleted by centrifugation at 800 g for 5 min. Cell pellet was then resuspended in sterile PBS and centrifuged at 800 g for 5 min. This step was repeated three times and erythrocytes were finally resuspended in Dulbecco’s modified essential medium (DMEM, Invitrogen) supplemented with 10% fetal calf serum (FCS, Invitrogen) at a concentration of 8%. One hundred μL were then added per well of sterile 96 well microplates (Greiner) containing 100 μL of DMEM +10% FCS with increasing concentrations of RumC1-5 (from 0 to 100 μM) obtained by 2-fold serial dilutions. Sterile water and Triton X-100 diluted in media at 0.1% (v/v) were used as negative and positive controls, respectively. After 1 h at 37°C, the microplates were centrifuged at 800 g for 5 min. One hundred μL of cell supernatants were collected and transferred to a new 96 well microplates and OD405 nm was measured using microplate reader (Synergy Mx, Biotek). Hemolysis caused by RumC1-5 was expressed as percentage of total hemolysis given by treatment with Triton X-100 at 0.1%. All experiments were done in triplicate.
+ Open protocol
+ Expand
5

ACL Cell Isolation and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
ACL samples obtained from the donors were cut into small uniform pieces under sterile conditions and transferred to six well plates (Corning, US) supplemented with growth medium.
Growth medium used was Dulbecco's Modified Eagle Medium (DMEM, Sigma-Aldrich, UK) F12 containing 50% foetal bovine serum (FBS, InvitrogenTM, UK) and 1% penicillin-streptomycin (InvitrogenTM, UK). Plates were incubated at standard conditions (37°C, 5% CO2) and growth medium was replaced every third day. Once cells had migrated from the explants, after approximately 7 days, the medium was refreshed with DMEM F12 containing 10% FBS.
Once cells had reached approximately 90% confluency, they were mechanically scraped and sub-cultured under the same conditions in 10 cm Petri dishes (Greiner, Germany) to allow proliferation. Cells were regularly checked for Mycoplasma infection using a MycoAlert testing kit (Lonza, UK), according to the manufacturer's instructions. ACL derived cells were used in the third passage for consistency and to avoid phenotypic drift.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!